Source: https://www.bankofengland.co.uk/-/media/boe/files/prudential-regulation/policy-statement/2026/january/ps126app1.pdf · captured 2026-09-29 · checked 2026-09-29 · c75b8196

Page 398 thumbnail
21105 This document is effective from 1 January 2027 to accompany PS1/26.
21106Please see: www.bankofengland.co.uk/prudential-regulation/publication/2026/january/implementation-of-basel-3-1-final-rules-policy-statement.
21107 PRA2026/1
21109 Organisational Structure and Control Mechanisms
21110 2.7 A CRR consolidation entity and a firm shall set up a proper organisational structure and
21111 appropriate internal control mechanisms in order to ensure that the data required for
21112 consolidation for the purposes of this Part are duly processed and forwarded.
21113 2.8 A CRR consolidation entity and a firm shall ensure that a subsidiary not subject to this Part
21114 implements arrangements, processes and mechanisms to ensure proper consolidation for the
21115 purposes of this Part.
21117 3 GENERAL PROVISIONS
21119 3.1 A firm must calculate its own funds requirements for CVA risk using the following approaches:
21120 (1) if it has permission to use SA-CVA, in accordance with Chapter 5;
21122 (2) if it does not have permission to use SA-CVA:
21124 (a) if 4.1 applies, BA-CVA under Chapter 4; or
21126 (b) if 6.1 applies, the alternative approach under Chapter 6.
21128 3.2 In addition to transactions that must be excluded under point (b) of Article 382(4) of CRR, a firm
21129 may exclude from its calculation of own funds requirements for CVA risk transactions that meet
21130 the following conditions:
21131 (1) the counterparty is:
21133 (a) included in the firm’s prudential consolidation group on a full basis; or
21135 (b) an entity in the firm’s group and the transaction between the counterparty and the firm
21136 is eliminated on accounting consolidation under the applicable accounting framework or
21137 the accounting standards applicable to the firm’s ultimate parent undertaking;
21139 (2) both the counterparty and the firm are subject to appropriate centralised risk evaluation,
21140 measurement and control procedures; and
21142 (3) there are no current or foreseen material practical or legal impediment to the prompt
21143 transfer of own funds or repayment of liabilities from the counterparty to the firm.
21145 3.3 A firm must:
21146 (1) notify the PRA in writing three months prior to the date at which it starts excluding
21147 transactions with a counterparty in accordance with 3.2 and confirm the notification every
21148 three years thereafter; and
21150 (2) include in each notification to the PRA:
21152 (a) the name of the counterparty excluded in accordance with 3.2; and
21154 (b) an explanation of how the conditions in 3.2 are met.
21156 3.4 A firm must:
21157 (1) if it hedges CVA risk, use only eligible CVA hedges;
21159 (2) not include external CVA hedges that are eligible CVA hedges in its calculation of its own
21160 funds requirements for market risk under the market risk Parts; and
21162 Page 398 of 492